| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |